Costliest Drugs in England — NHS Prescribing Data — Page 2
Page 2 of 89
| # | Drug | Category | NHS Cost | Items |
|---|---|---|---|---|
| 31 | Salbutamol | Respiratory System | £60.9M | 19.7M |
| 32 | Pancreatin | Gastro-Intestinal System | £59.0M | 734.6K |
| 33 | Dulaglutide | Endocrine System | £58.7M | 710.6K |
| 34 | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | £58.2M | 15.1M |
| 35 | Methylphenidate hydrochloride | Central Nervous System | £57.9M | 1.8M |
| 36 | Tiotropium bromide | Respiratory System | £56.8M | 2.1M |
| 37 | Calcipotriol | Skin | £56.7M | 1.2M |
| 38 | BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | Respiratory System | £55.0M | 1.1M |
| 39 | Adrenaline | Respiratory System | £54.4M | 428.6K |
| 40 | Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | £52.7M | 833.9K |
| 41 | Lisdexamfetamine dimesylate | Central Nervous System | £52.4M | 767.5K |
| 42 | Apixaban | Cardiovascular System | £50.0M | 9.6M |
| 43 | Quetiapine | Central Nervous System | £48.7M | 4.5M |
| 44 | Buprenorphine | Central Nervous System | £47.6M | 2.7M |
| 45 | Leuprorelin acetate | Malignant Disease and Immunosuppression | £47.5M | 256.7K |
| 46 | Appliances | £45.6M | 4.8M | |
| 47 | Melatonin | Central Nervous System | £45.3M | 2.4M |
| 48 | Umeclidinium bromide/vilanterol | Respiratory System | £45.2M | 1.3M |
| 49 | Sertraline hydrochloride | Central Nervous System | £45.2M | 24.6M |
| 50 | Venlafaxine | Central Nervous System | £43.0M | 6.1M |
| 51 | Insulin degludec | Endocrine System | £43.0M | 723.7K |
| 52 | Levothyroxine sodium | Endocrine System | £42.7M | 34.5M |
| 53 | Progesterone | Endocrine System | £41.7M | 2.9M |
| 54 | Lansoprazole | Gastro-Intestinal System | £40.4M | 36.6M |
| 55 | Ready to serve 1.5 kcal/ml milkshake (0913011) | Nutrition and Blood | £39.6M | 962.0K |
| 56 | Appliances | £39.5M | 7.7M | |
| 57 | Alogliptin | Endocrine System | £38.1M | 1.4M |
| 58 | Stoma Appliances | £38.0M | 227.7K | |
| 59 | Appliances | £37.9M | 197.4K | |
| 60 | Goserelin acetate | Malignant Disease and Immunosuppression | £37.9M | 248.4K |